February 1, 2024 Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
December 13, 2023 Certara Acquires Applied Biomath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies
November 21, 2023 Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development
October 11, 2023 Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference
September 19, 2023 Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software